Cargando…

Model-based lamotrigine clearance changes during pregnancy: clinical implication

OBJECTIVE: The objective of the study was to characterize changes in the oral clearance (CL/F) of lamotrigine (LTG) over the course of pregnancy and the postpartum period through a model-based approach incorporating clinical characteristics that may influence CL/F, in support of developing clinical...

Descripción completa

Detalles Bibliográficos
Autores principales:	Polepally, Akshanth R, Pennell, Page B, Brundage, Richard C, Stowe, Zachary N, Newport, Donald J, Viguera, Adele C, Ritchie, James C, Birnbaum, Angela K
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BlackWell Publishing Ltd 2014
Materias:	Research Papers
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4038031/ https://www.ncbi.nlm.nih.gov/pubmed/24883336 http://dx.doi.org/10.1002/acn3.29

Ejemplares similares

Pharmacokinetic changes and therapeutic drug monitoring of lamotrigine during pregnancy
por: Ding, Ye, et al.
Publicado: (2019)

Are doses of lamotrigine or levetiracetam adjusted during pregnancy?
por: Richards, Noni, et al.
Publicado: (2017)

Exposure–Response Relationships for Efficacy and Safety of Risankizumab in Phase II and III Trials in Psoriasis Patients
por: Khatri, Amit, et al.
Publicado: (2019)

Levetiracetam, lamotrigine and carbamazepine: which monotherapy during pregnancy?
por: Mari, Luisa, et al.
Publicado: (2021)

Exposure‐Safety Analyses Identify Predictors of Change in Bone Mineral Density and Support Elagolix Labeling for Endometriosis‐Associated Pain
por: Abbas Suleiman, Ahmed, et al.
Publicado: (2020)

Pharmacotherapeutics of epilepsy: use of lamotrigine and expectations for lamotrigine extended release
por: Werz, Mary Ann
Publicado: (2008)

Effect of Elagolix Exposure on Clinical Efficacy End Points in Phase III Trials in Women With Endometriosis‐Associated Pain: An Application of Markov Model
por: Winzenborg, Insa, et al.
Publicado: (2020)

Olanzapine-induced electroencephalographic changes reversed by lamotrigine
por: Velur, Prasuna L., et al.
Publicado: (2012)

Cardiac sodium channel inhibition by lamotrigine: In vitro characterization and clinical implications
por: Ingleby‐Talecki, Lindsey, et al.
Publicado: (2022)

Acute localized exanthematous pustulosis (ALEP) caused by lamotrigine
por: Hopkins, Zachary, et al.
Publicado: (2018)

The effect of lamotrigine on epilepsy
por: Ebrahimi, Hossein Ali, et al.
Publicado: (2012)

Lamotrigine ethanol monosolvate
por: Hall, Charlie L., et al.
Publicado: (2018)

Lamotrigine use in pregnancy and risk of orofacial cleft and other congenital anomalies
por: Dolk, Helen, et al.
Publicado: (2016)

Lamotrigine Hypersensitivity Syndrome and Spiking Fever
por: Bakker, Christiaan V, et al.
Publicado: (2012)

Adverse Effects of Antiepileptic Drug Lamotrigine and Oral Implications: Case Report
por: Malčić, Ana Ivanišević, et al.
Publicado: (2017)

Lamotrigine-Associated Progressive Dysphasia and Cognitive Dysfunction
por: Brown, Joshua C., et al.
Publicado: (2021)

Dosing Recommendations for Concomitant Medications During 3D Anti-HCV Therapy
por: Badri, Prajakta S., et al.
Publicado: (2015)

Effects of Maternal Exposure to Lamotrigine during Pregnancy on Gonadal Toxicity in Fetus Rats
por: Aryan, Hoda, et al.
Publicado: (2020)

Successful management of massive lamotrigine extended‐release intoxication in a dog
por: McLaine, Alexis S., et al.
Publicado: (2021)

Lamotrigine induced DRESS syndrome
por: Naveen, Kikkeri Narayanasetty, et al.
Publicado: (2012)

Pulmonary damage caused by lamotrigine
por: Mon, Yusuke, et al.
Publicado: (2020)

Lamotrigine-Induced Acute Pancreatitis
por: Elmusa, Emad, et al.
Publicado: (2022)

Chorea Associated with Lamotrigine Use
por: Rael, Sofia, et al.
Publicado: (2023)

Lamotrigine-Induced Lupus With Aseptic Meningitis and Hemophagocytic Lymphohistiocytosis
por: Tran, Dena H, et al.
Publicado: (2022)

The role of lamotrigine in the management of bipolar disorder
por: Ng, Felicity, et al.
Publicado: (2007)

Influence of nebivolol on anticonvulsant effect of lamotrigine
por: Goel, Radha, et al.
Publicado: (2009)

Action Tremor Associated with Lamotrigine Monotherapy
por: Yang, Ji-Hye, et al.
Publicado: (2010)

Stevens Johnson Syndrome associated with Lamotrigine
por: Parveen, Shama, et al.
Publicado: (2013)

Severe lamotrigine toxicosis in a dog
por: Sawyer, Danielle, et al.
Publicado: (2017)

Rechallenge of lamotrigine after development of rash
por: Houser, Jennifer, et al.
Publicado: (2018)

Lamotrigine: Haemophagocytic lymphohistiocytosis: case report
Publicado: (2022)

Lamotrigine Drug Interactions: Ignorance is not Bliss
por: Armstrong, Austin G., et al.
Publicado: (2022)

Sinus Bradycardia in an Adolescent Taking Lamotrigine
por: Davis, Genevieve, et al.
Publicado: (2022)

Serologic Presentation of Lamotrigine-Induced Lupus
por: Dempsey, Hannah, et al.
Publicado: (2022)

Lamotrigine-associated toxic epidermal necrolysis
por: Farooq, Omair, et al.
Publicado: (2023)

Bimodal Gastroretentive Drug Delivery Systems of Lamotrigine: Formulation and Evaluation
por: Poonuru, R. R., et al.
Publicado: (2014)

Assessment of Clinical Drug‐Drug Interactions of Elagolix, a Gonadotropin‐Releasing Hormone Receptor Antagonist
por: Polepally, Akshanth R., et al.
Publicado: (2020)

Is ketamine and lamotrigine interactions responsible for the sub-therapeutic effect of ketamine?
por: Adnan, M., et al.
Publicado: (2021)

Validation of a quantitative systems pharmacology model of calcium homeostasis using elagolix Phase 3 clinical trial data in women with endometriosis
por: Stodtmann, Sven, et al.
Publicado: (2021)

Toxic epidermal necrolysis due to lamotrigine in a pediatric patient
por: Barvaliya, Manish J., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_kbjc9au0esvmrne6pksbcocfjl